JPMorgan Chase Boosts Stake in Pediatrix Medical Group

Investment firm increases ownership in healthcare provider by 20.5%

Mar. 28, 2026 at 8:59am

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has grown its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 20.5% during the third quarter, according to a recent SEC filing. The investment firm now owns 827,075 shares of the company's stock, representing a 0.96% ownership position.

Why it matters

This move by one of the world's largest investment banks signals confidence in Pediatrix's future prospects as a leading provider of neonatal, maternal-fetal, and pediatric subspecialty care services. The increased stake could indicate JPMorgan's belief in Pediatrix's growth potential and ability to navigate industry challenges.

The details

According to the 13F filing, JPMorgan Chase added 140,577 shares of Pediatrix Medical Group to its portfolio during the third quarter. The firm now holds a total of 827,075 shares, worth approximately $13.85 million based on the company's current stock price.

  • JPMorgan Chase & Co. increased its stake in Pediatrix Medical Group during the 3rd quarter of 2026.

The players

JPMorgan Chase & Co.

One of the world's largest investment banks and financial services firms.

Pediatrix Medical Group, Inc.

A national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care.

Got photos? Submit your photos here. ›

The takeaway

This investment by JPMorgan Chase suggests the firm sees long-term value in Pediatrix Medical Group's specialized healthcare services and ability to navigate industry changes. The increased stake could signal confidence in the company's growth prospects and strategic direction.